Compound information
- Natural Products
- ZC3401557
- Molecular Formula
- C35H38N8O4
- Molecular Weight
- 634.301601696 g/mol
- Structure
-
- IUPAC Name
- N-[4-[[3-(3,5-dimethoxyphenyl)-7-[4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]methyl]phenyl]prop-2-enamide
- InChI
- InChI=1S/C35H38N8O4/c1-5-32(44)37-26-8-6-24(7-9-26)22-43-33-25(23-42(35(43)45)29-18-30(46-3)20-31(19-29)47-4)21-36-34(39-33)38-27-10-12-28(13-11-27)41-16-14-40(2)15-17-41/h5-13,18-21H,1,14-17,22-23H2,2-4H3,(H,37,44)(H,36,38,39)
- InChI Key
- DVBPRWJMHURKHP-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(CN2C(=O)N(c3cc(OC)cc(OC)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)cc1
- Source
- ZINC000250363839
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 47 | Ring Count | 6 |
Heteroatom Count | 12 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 9 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 115.4 Å2 | LogP | 4.876 |
LogS | -5.376 | LogD | 4.002 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.995 | Pgp substrate | 0.98 |
HIA | 0.954 | F20 % | 0.975 |
F30 % | 0.209 | Caco-2 | -5.537 |
MDCK | -5.401 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.094 | PPB | 91.515 |
VD | 1.34 | Fu | 2.125 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.593 |
CYP2A6 substrate | 0.065 | CYP2B6 substrate | 0.468 |
CYP2C19 inhibitor | 0.177 | CYP2C19 substrate | 0.934 |
CYP2C8 substrate | 0.948 | CYP2C9 inhibitor | 0.071 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.53 |
CYP2D6 substrate | 0.918 | CYP2E1 substrate | 0.163 |
CYP3A4 inhibitor | 0.894 | CYP3A4 substrate | 0.995 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.321 | CL | 5.087 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.815 | Hepatotoxicity | 0.998 |
Mutagenicity | 0.312 | Rat Oral Acute Toxicity | 0.127 |
FDAMDD | 0.947 | Skin Sensitization | 0.94 |
Carcinogenicity | 0.187 | Eye Corrosion | 0.006 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.925 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.735 | IGC50 | 3.817 |
LC50FM | -12.21 | LC50DM | -12.005 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.65 | NR-AR-LBD | 0.502 |
NR-AhR | 0.601 | NR-Aromatase | 0.067 |
NR-ER | 0.688 | NR-ER-LBD | 0.625 |
NR-PPAR-gamma | 0.847 | SR-ARE | 0.944 |
SR-ATAD5 | 0.915 | SR-HSE | 0.304 |
SR-MMP | 0.923 | SR-p53 | 0.939 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.